Cleared Traditional

K251447 - K-Pack Embrace Active Safety Needle (KN...

K251447 is the FDA 510(k) clearance for K-Pack Embrace Active Safety Needle (KN... by Terumo Europe N.V.. It is a Class 2 General Hospital device (product code FMI) cleared through the Traditional 510(k) pathway after a 60-day FDA review.

K251447 · Terumo Europe N.V. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2025
Decision
60d
Days
Class 2
Risk

K251447 is an FDA 510(k) clearance for the K-Pack Embrace Active Safety Needle (KNAS-2516RB, KNAS-2525RB). Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Terumo Europe N.V. (Leuven, BE). The FDA issued a Cleared decision on July 8, 2025 after a review of 60 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Terumo Europe N.V. devices

Submission Details

510(k) Number K251447 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2025
Decision Date July 08, 2025
Days to Decision 60 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 129d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 235
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K251447.
Profoject™ Disposable Needle
K252631 · CMT Health PTE., Ltd. · Oct 2025
Intraosseous Infusion Needles
K250724 · Spectrum Vascular · Jul 2025
TSK SELECT™ Needle
K250284 · Tsk Laboratory, Japan · Jul 2025
27G x 1/2 TW K-Pack Surshield Needle (KN-S2713RBT)
K243309 · Terumo Europe N.V. · May 2025
FROG (Filter Removal of Glass)
K240355 · Carrtech Corp · Apr 2025
K-Pack Enhance Needle (KH-2713RBBTC and KH-2913RBBTC)
K243581 · Terumo Europe N.V. · Apr 2025